Express Pharma - Page 159 of 2207 - Express Pharma

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy

The fine line between reform and risk

FOPE seeks CDSCO clarification on pharmacovigilance obligations under revised Schedule M

Asahi Kasei establishes life science division to streamline bioprocess operations for pharma sector

How pharma is learning to talk—and listen

Steris Healthcare announces ₹50 crore expansion and IPO plans for FY 2026–27

DHL Group commits €2 billion to expand life sciences and healthcare logistics by 2030

Pharma M&A and VC activity declines in March 2025, reports GlobalData

Roche’s Brainshuttle technology promises next generation of amyloid beta mAbs, says GlobalData

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Pharma & Med Devices Supply Chain Conclave 2025 | 9th May 2025

Sun Pharma launches FEXUCLUE (Fexuprazan) in India for treatment of Erosive Esophagitis

Prasinezumab hints PD progression delay as assessed by time-to-event: GlobalData